ROLE OF GSK-3 IN THE PATHOGENESIS OF CORONARY HEART DISEASE

Cardiovascular disease is the leading cause of morbidity and mortality worldwide. A strategy for early diagnosis of cardiovascular disease can help reduce the number of complications and deaths in patients. Research by the world's leading scientists is aimed at studying the pathogenetic links underlying the development of heart disease. The study of the molecular signaling pathways responsible for the induction of cardiac hypertrophy is of great clinical interest, and the potential therapeutic use of these molecules could prevent or slow down pathological myocardial remodeling and heart failure leading to cardiomyocyte death or dysfunction. The article discusses the influence of the components of the immune system on the pathogenesis of cardiovascular diseases. The role of GSK-3 kinase, which plays an important role in the regulation of proliferation, differentiation, apoptosis, and metabolic processes in the cell, as well as participates in the regulation of various signaling pathways, including Wnt / β-catenin and TGF-β-signaling, has been evaluated. Serum levels of GSK-3α and GSK-3β, as well as pro- and anti-inflammatory cytokines (IL-1β, IL-10 and TNF-α) were assessed in patients with coronary artery disease (myocardial infarction and unstable angina pectoris) and relatively healthy persons. The relationship of these indicators with clinical and laboratory data has been analyzed. The results obtained indicate the important role of immune processes in the pathogenesis of coronary heart disease. The performed combinatorial analysis of glycogen synthase kinase 3, serum cytokines with laboratory data (leukocyte and LDL levels) can help assess the severity of coronary heart disease and can help in determining risk stratification in patients with angina pectoris.